Table 3.
Literature on musculoskeletal infections in patients with IDA
| Authors | Year | Patient number | Time period | Location | Diagnosis | Gram N | PA* | S aureus | ORSA* | Strep | S epi | AN | F | MB | Poly |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kido et al. [11] | 1973 | 32 | 1969–71 | USA | OM: 32 | 32 (100%) | 27 (84%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gifford et al. [7] | 1975 | 10 | 1970–73 | USA | SA: 10 | 10 (100%) | 10 (100%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Roca and Yoshikawa [18] | 1979 | 24 | 1969–78 | USA | OM: 14 SA: 10 | 15 (63%) | 14 (58%) | 4 (17%) | N/A | 2 (8%) | 1 (4%) | 0 | 1 (4%) | 1 (4%) | 3 (13%) |
| Miskew et al. [14] | 1983 | 35 | 1976–79 | USA | OM: 17 SA: 18 | 35 (100%) | 35 (100%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ang-Fonte et al. [2]# | 1985 | 28 (21 IDA) | 1981–82 | USA | SA: 21 | 3 (11%) | 0 | 18 (64%) | 7 (25%) | 8 (29%) | 1 (4%) | 0 | 0 | 0 | 2 (7%) |
| Chandrasekar and Narula [6] | 1986 | 45 | 1982–83 | USA | OM: 7 SA: 33 Both: 5 | 7 (16%) | 5 (11%) | 25 (56%) | 16 (36%) | 14 (31%) | 0 | 1 (2%) | 0 | 0 | 2 (4%) |
| Lopez-Longo et al. [13] | 1987 | 37 | 1982–84 | Spain | SA: 37 | 0 | 0 | 27 (73%) | N/A | 1 (3%) | 0 | 0 | 5 (14%) | 0 | 0 |
| Brancos et al. [5] | 1991 | 35 | 1982–88 | Spain | SA: 35 | 5 (14%) | 4 (11%) | 27 (77%) | 1 (3%) | 1 (3%) | 0 | 0 | ^ | ^ | 0 |
| Munoz-Fernandez et al. [15] | 1993 | 31 | 1981–90 | Spain | SA: 31 | 0 | 0 | 17 (55%) | N/A | 0 | 0 | 0 | 6 (19%) | 2 (6%) | 0 |
| Belzunegui et al. [4] | 2000 | 34 | 1979–99 | Spain | SA: 27 OM: 6 Other: 1 | 2 (6%) | 0 | 25 (74%) | N/A | 1 (3%) | 1 (3%) | 0 | 3 (9%) | 2 (6%) | 0 |
| Allison et al. [current study] | 2010 | 215 | 1998–2005 | USA | OM: 127 SA: 53 Both: 35 | 40 (19%) | 15 (7%) | 111 (52%) | 43 (20%) | 38 (18%) | 42 (20%) | 27 (13%) | 9 (4%) | 0 | 70 (33%) |
IDA: Injecting drug abuse, OM: Osteomyelitis, SA: Septic arthritis, Gram N: Gram negative organisms, PA: Pseudomonas aeruginosa, ORSA: oxacillin-resistant Staphylococcus aureus, Strep: Streptococci, Staphylococcus epidermidis, AN: Anaerobes, F: Fungi, MB: Mycobacteria, Poly: Polymicrobial, N/A: data not available.
* Please note that the number of Pseudomonas aeruginosa infections is included in the Gram negative infections and that the number of ORSA infections is included in the S aureus infections.
# Percentages are calculated with the total number of 28 patients as the denominator. No data were provided specifically for the 21 patients with IDA.
^ Fungal and mycobacterial infections were included in this study.